Infusion Systems Market in Japan 2016-2020
About the Infusion Systems Market in Japan
An infusion system is an external pump used to deliver regulated amounts of drugs and nutrients to individuals through intravenous, epidural or enteral, and subcutaneous routes. Drugs delivered using the system include antibiotics, insulin and other hormones, pain relief medications, and chemotherapeutics. The system involves the use of needles for the intermediate active transport of drugs and fluids across biological membranes. Infusions pumps help administer fluids in situations where other methods are not feasible. For instance, infusion systems can deliver fluids at rates as low as 0.1 ml/hour.
Technavio’s analysts forecast the infusion systems market in Japan to grow at a CAGR of 6.62% during the period 2016-2020.
Covered in this report
The report covers the present scenario and the growth prospects of the infusion systems market in Japan for 2016-2020. To calculate the market size, we consider revenue generated from the sales of:
Technavio Announces the Publication of its Research Report – Infusion Systems Market in Japan 2016-2020
Technavio recognizes the following companies as the key players in the infusion systems market in Japan: B. Braun Melsungen, Baxter, BD, Fresenius Kabi, Hospira, JMS, Nipro, and Terumo.
Other Prominent Vendors in the market are: Animas, Medtronic, and Smiths Medical.
Commenting on the report, an analyst from Technavio’s team said: “A trend which is positively impacting the market is the availability of IT-enabled devices. Advances in technology and incorporation of IT-enabled components have significantly increased the efficiency of infusion systems. IT-enabled infusion systems offer advanced features, such as automatic recording of information regarding fluid flow, and optimal use of nutrients, fluid, and blood with less wastage and leakage. These features help enhance patient safety, reduce medical errors, increase the efficacy of dosages, and streamline information processing. IT-enabled infusion systems also help reduce costs and timelines associated with treatments.”
According to the report, a key growth driver is the rising use of chemotherapy. Over the past few years, chemotherapy is gaining popularity as a treatment option for cancer. The therapy involves the infusion of cytotoxic anti-neoplastic drugs and other medications directly into the bloodstream to inhibit the growth and spreading of cancer cells. Infusion systems provide short-term access to the bloodstream. Physicians use these systems to deliver chemotherapeutic agents to individuals receiving chemotherapy once every few weeks. Integrated or closed catheters offer fully (360 degrees) encased needle tip protection and have a passive design to minimize needle-stick injuries.
Further, the report states that one challenge that could restrict market growth is the complications associated with infusion systems.
B. Braun Melsungen, Baxter, BD, Fresenius Kabi, Hospira, JMS, Nipro, Terumo, Animas, Medtronic, and Smiths Medical.